NYSE · Healthcare
QUEST DIAGNOSTICS INC (DGX)
As-reported financials and recent SEC filings for QUEST DIAGNOSTICS INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$11.04B
Net income
$992.0M
Net margin
9.0%
Diluted EPS
$8.75
ROE
13.8%
P/E (TTM)
23.2×
Market cap
$23.23B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| Gross profit | $3.67B | $3.24B | $3.05B | $3.43B | $4.21B |
| Operating income | $1.56B | $1.35B | $1.26B | $1.43B | $2.38B |
| Net income | $992.0M | $871.0M | $854.0M | $946.0M | $2.00B |
| Diluted EPS | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
11-K2026-06-18
View on EDGAR →42026-06-08
View on EDGAR →1442026-06-04
View on EDGAR →42026-06-02
View on EDGAR →1442026-06-01
View on EDGAR →42026-05-21
View on EDGAR →42026-05-21
View on EDGAR →42026-05-21
View on EDGAR →Go deeper on DGX
Search QUEST DIAGNOSTICS INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.